| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | -0.059 | 0.2 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.2 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.2 |
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | -0.067 | 0.2 |